ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PYC Physiomics Plc

1.30
-0.20 (-13.33%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -13.33% 1.30 1.20 1.40 1.30 1.05 1.25 2,479,405 10:28:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -3.71 1.76M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.50p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £1.76 million. Physiomics has a price to earnings ratio (PE ratio) of -3.71.

Physiomics Share Discussion Threads

Showing 24376 to 24398 of 30150 messages
Chat Pages: Latest  978  977  976  975  974  973  972  971  970  969  968  967  Older
DateSubjectAuthorDiscuss
19/6/2020
15:32
There are no institutional buyers and there never evr has been.

Unless you call jc aka ZA an institution

spacedust
19/6/2020
15:24
When the Merck deal happened the reason it went up 30x (and was going to 50x) wasn't just because they did a €500k deal with Merck KGaA.

Remember Day 1 it went up about 200-300%
Day 2 it went up another 100%
Day 3 it went up about 300% before finishing up about up 50%

Anyway you get the pucture it took a while for the Market to latch onto what the Contract meant

1. It was validation of PYC technology
2. It represented a step change in Revenues
3. It meant PYC would suddenly be taken more seriously by others ( Customers: Big Pharmas , Small/Medium Bios; Competitors; Partners etc)

One thing i didn't appreciate at the time was how far ahead Merck KGaA are. They aren't 'Leading Edge' they are 'Bleeding Edge'. They are so highly regarded in this Immuno-Oncology field other Big Pharma like GSK and PFE Pfizer partner with them.

So now if PYC land a Large Pharma similar dynamics and positive feedback loops are initiated.

Lots of customers will have more confidence to go with them. Lots of peers may want to partner (Certara/Schrodinger)

In investor terms Certara/Schrodinger are biggies. They are ultimate most likely acquirers of PYC as a business. PYC clearly aware of industry M&A note recent tweets about $SLP deal and Parexel acquisition of Model Answers.

Then on top of all that we may get more Broker coverage and Institutional buyers. That is why i expect 20p+ on a sustained basis

the stigologist
19/6/2020
14:34
Yes please. JC are you on board? It's imperative you are for a sustained rise otherwise goodbye double digits
spacedust
19/6/2020
14:26
Spread tightened, afternoon rally about to commence? ?
aimbagger
19/6/2020
13:08
Fomo and us buying doesn't need to wait until 230pm to start buying our markets are open you numpty dumpty humpty scumpty
spacedust
19/6/2020
13:07
125k is my buy not a sell
herb clark
19/6/2020
12:58
Cannot buy any as no quote avaialble
carlisle44
19/6/2020
12:39
Rolaw the thing about days and weeks is that they turn to yrs and in my case decade.....s
spacedust
19/6/2020
12:28
FOMO and US buying to kick in this PM ?
the stigologist
19/6/2020
11:47
We all know news can't be far away. Just a case of a little more patience. I am really hopeful that patience will be rewarded. I have been in here a few years, what's a few more days/weeks/months!!
rolaw1
19/6/2020
11:46
VAL could be the next one to move like this all IMHO.
412069
19/6/2020
11:40
Contract news hasn't even landed yet, anticipation likely to build this afternoon in case it hits on Monday at 7am.
aimbagger
19/6/2020
11:12
Back down to earth.

Some Thing leaked
Comparitors galore

Where are these comments now. Jim the cunning sold out his shares at 8p

spacedust
19/6/2020
08:54
Doc Robinson19 Jun '20 - 06:08 - 5757 of 5762
0 0 0
Will this hit double figures today with or without a RNS ??

Simple answer NO!

chesty1
19/6/2020
08:34
See if we can crack through 8p today! ?
aimbagger
19/6/2020
07:01
9.4p today
chicken charlie
19/6/2020
06:36
Doc go back to bed
chicken charlie
19/6/2020
06:08
Will this hit double figures today with or without a RNS ??
doc robinson
19/6/2020
06:08
An excellent day yesterday.It would be even better to see a share price that reflected the off balance sheet value of the technology which is of course, MULTIPLES of where we are now. It has taken some 20 YEARS to develop and is still well ahead of the curve being world class in every respect.
ant15
18/6/2020
22:42
I went inside doc browns time machine and got the rns.

Some younger peeps scratching their heads thinking who on earth is doc brown

spacedust
18/6/2020
22:39
TIDMPYC

Physiomics PLC

XX June 2020

Physiomics plc

("Physiomics") or (the "Company")

Physiomics awarded further contract

Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models and its Virtual Tumour(TM) technology to support the development of cancer treatment regimens and personalised medicine solutions, is pleased to announce that it has been awarded a further contract of undisclosed value with a large pharmaceutical bio-tech company listed on the Nasdaq exchange.

The Project is an extension of the work the Company completed on (currently in a Cancer Research UK-sponsored Phase I/IIa study), which Physiomics announced earlier this year.

Physiomics' role is related to the analysis of clinical data from this trial and its work on the initial project was acknowledged in a poster presentation, The Project is expected to be completed in the next six months.

Dr Jim Millen, CEO said : "We are delighted to continue to expand our relationship with a key high-profile client. It's also pleasing that we are able to sign new business in the current environment and hope to see this continue over the course of the rest of this calendar year."

spacedust
18/6/2020
22:35
Here is the fifth coming rns
spacedust
18/6/2020
20:54
Your next rns of a new contract will seriously disappoint any new investors new to this company. It will either mention no revenue, or it will be a few thousand.

Don't be foolish.

davevt
Chat Pages: Latest  978  977  976  975  974  973  972  971  970  969  968  967  Older

Your Recent History

Delayed Upgrade Clock